Quantcast
Latest Stories

Controlling blood sugar the natural way



Diabetes care pioneer Novo Nordisk has developed a novel type of medicine for type 2 diabetes that controls blood sugar the natural way.

“Liraglutide mimics the action of a hormone released from the small intestine after food intake. This hormone, a type of incretin called GLP-1, helps the pancreas control blood sugar more efficiently,” said Diabetes Research Division head Dr. Filip K. Knop of the  Gentofte Hospital, University of Copenhagen, Denmark.

“Liraglutide signals the pancreas to secrete more insulin to help lower blood sugar quickly. At the same time, it suppresses the pancreas from secreting too much glucagon, a hormone that releases glucose from the liver and raises blood sugar levels,” said Makati Medical Center consultant endocrinologist Dr. Augusto D. Litonjua.

The two experts spoke during a lunch symposium organized by Novo Nordisk on March 20, at the Edsa Shangri-La Hotel in Mandaluyong City. Around 200 local internists, cardiologists and endocrinologists attended the symposium.

Liraglutide belongs to a class of diabetes medicines called GLP-1 receptor agonists. Also called incretin mimetics, GLP-1 receptor agonists mimic the action of intestinal GLP-1. While the effects of GLP-1 only last for a few minutes, the half-life of liraglutide is about 10-13 hours.

Liraglutide is 97 percent similar to GLP-1. By acting like GLP-1, liraglutide helps make more insulin available in the bloodstream to help lower blood sugar levels quickly. Liraglutide triggers important cells in the pancreas, called beta cells, to make insulin when blood sugar is high. This is important because, over time, beta cells stop working in people with type 2 diabetes. By the time of diagnosis, about 50 percent of beta cells are no longer working the way they should. Liraglutide helps beta cells work the way they should.

Unique mechanism of action

“Unlike other anti-diabetes medications [e.g. sulphonylureas] that stimulate insulin secretion all the time, liraglutide stimulates insulin secretion only when there is a need for it—after a meal when blood sugar levels are high,” said Dr. Knop. “Because of its unique mechanism of action, liraglutide does not cause hypoglycemia [low blood sugar], a dangerous condition associated with certain anti-diabetes medications.”

“GLP-1 receptor agonists such as liraglutide provide multiple benefits to patients with type 2 diabetes,” said Dr. Litonjua. These include normalizing after-meal (postprandial) blood sugar levels, suppressing inappropriately high glucagon secretion, improving beta cell responsiveness and nighttime insulin secretion, decreasing appetite and weight, and significantly lowering HbA1c, a key measure of diabetes control.

Liraglutide is a once-a-day injectable medication indicated for the treatment of type 2 diabetes when diet and exercise alone are not enough to control blood sugar levels. It can be used together with other diabetes medications, such as metformin, sulfonylureas [e.g. glimepiride or glicazide] and pioglitazone. Liraglutide comes in a prefilled pen that is injected at any time of the day under the skin of the stomach, thigh, or upper arm. Philippine Daily Inquirer


Follow Us


Follow us on Facebook Follow on Twitter Follow on Twitter


Recent Stories:

Complete stories on our Digital Edition newsstand for tablets, netbooks and mobile phones; 14-issue free trial. About to step out? Get breaking alerts on your mobile.phone. Text ON INQ BREAKING to 4467, for Globe, Smart and Sun subscribers in the Philippines.

Tags: blood sugar , diabetes , Health

  • http://www.facebook.com/bobbydecastro Bienvenido G. de Castro

    Endocrinologists should take note of this medical discovery. It is a good development.



Copyright © 2014, .
To subscribe to the Philippine Daily Inquirer newspaper in the Philippines, call +63 2 896-6000 for Metro Manila and Metro Cebu or email your subscription request here.
Factual errors? Contact the Philippine Daily Inquirer's day desk. Believe this article violates journalistic ethics? Contact the Inquirer's Reader's Advocate. Or write The Readers' Advocate:
c/o Philippine Daily Inquirer Chino Roces Avenue corner Yague and Mascardo Streets, Makati City, Metro Manila, Philippines Or fax nos. +63 2 8974793 to 94
Advertisement
Advertisement

News

  • Russia promises support to ending Ukraine crisis
  • Busted valve delays water interruption
  • Cardinal Tagle decries human ‘commercialization’
  • Religion builds bridges in ethnically split Cyprus
  • Iran general urges Tehran to make new UN pick
  • Sports

  • Vettel hoping for resurgence at Chinese GP
  • MLB pitcher donates $100,000 for Sewol ferry victims
  • Hamilton takes pole at Chinese Grand Prix
  • Duke’s Rodney Hood joining Jabari Parker in NBA draft
  • Phelps entered in 3 events at comeback meet
  • Lifestyle

  • Levine designs womenswear with help from fiancee
  • Gabriel Garcia Marquez, Nobel laureate, dies at 87
  • Ford Mustang turns 50 atop Empire State Building
  • Pro visual artists, lensmen to judge Pagcor’s photo contest
  • ‘Labahita a la bacalao’
  • Entertainment

  • Myx TV premieres Asian American ‘docu-series’
  • A nutty finale for ‘Scandal,’ TV’s craziest show
  • EXO postpones release of mini album ‘Overdose’
  • ‘X-men’ filmmaker slams ‘fabricated’ sex attack claims
  • Singer Chris Brown’s bodyguard on trial in DC
  • Business

  • Fiat-Chrysler to produce iconic Jeep in China from 2015
  • US commerce secretary spells out economic facet of ‘pivot to Asia’
  • Italy sells luxury state cars on eBay
  • Asian shares mostly up in quiet trade
  • Dollar up in Asia on US jobs data, Ukraine deal
  • Technology

  • Nasa’s moon-orbiting robot crashes down
  • Netizens pay respects to Gabriel Garcia Marquez
  • Nokia recalls 30,000 chargers for Lumia 2520 tablet
  • Facebook rolls out ‘nearby friends’ feature
  • Netizens seethe over Aquino’s ‘sacrifice’ message
  • Opinion

  • Editorial cartoon, April 17, 2014
  • A humbler Church
  • Deepest darkness
  • ‘Agnihotra’ for Earth’s health
  • It’s the Holy Week, time to think of others
  • Global Nation

  • DOH to continue tracking co-passengers of OFW infected with MERS virus
  • 5 Filipinos with MERS in UAE reported in stable condition
  • PH boosts MERS monitoring after UAE nurse scare
  • Canadians back PH plea to take back waste
  • We treasure our Sierra Madre
  • Marketplace